BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 31821092)

  • 1. Weighted Gene Co-Expression Network Analysis Reveals Six Hub Genes Involved in and Tight Junction Function in Pancreatic Adenocarcinoma and their Potential Use in Prognosis.
    Xia WX; Zhang LH; Liu YW
    Genet Test Mol Biomarkers; 2019 Dec; 23(12):829-836. PubMed ID: 31821092
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
    Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
    Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
    Tian C; Li X; Ge C
    Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma.
    Zheng X; Liu X; Zheng H; Wang H; Hong D
    Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma.
    Gu X; Zhang Q; Wu X; Fan Y; Qian J
    World J Surg Oncol; 2021 Apr; 19(1):112. PubMed ID: 33845841
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential four‑miRNA signature associated with T stage and prognosis of patients with pancreatic ductal adenocarcinoma identified by co‑expression analysis.
    You L; Wang J; Zhang F; Zhang J; Tao H; Zheng X; Hu Y
    Mol Med Rep; 2019 Jan; 19(1):441-451. PubMed ID: 30483731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort.
    Jie Y; Peng W; Li YY
    Aging (Albany NY); 2021 Feb; 13(4):5698-5717. PubMed ID: 33591944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
    Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the Real Hub Gene and Construction of a Novel Prognostic Signature for Pancreatic Adenocarcinoma Based on the Weighted Gene Co-expression Network Analysis and Least Absolute Shrinkage and Selection Operator Algorithms.
    Yuan Q; Ren J; Wang Z; Ji L; Deng D; Shang D
    Front Genet; 2021; 12():692953. PubMed ID: 34490033
    [No Abstract]   [Full Text] [Related]  

  • 13. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
    Giulietti M; Occhipinti G; Principato G; Piva F
    Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
    Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
    Li F; Zhang P
    Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.
    Huang X; Zhang G; Tang T; Liang T
    Mol Cancer; 2021 Mar; 20(1):44. PubMed ID: 33648511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis.
    Chen S; Liu Z; Li M; Huang Y; Wang M; Zeng W; Wei W; Zhang C; Gong Y; Guo L
    Curr Gene Ther; 2020; 20(1):5-14. PubMed ID: 32416689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel potential homologous repair deficiency-associated genes in pancreatic adenocarcinoma via WGCNA coexpression network analysis and machine learning.
    Liu C; Fang J; Kang W; Yang Y; Yu C; Chen H; Zhang Y; Ouyang H
    Cell Cycle; 2023 Nov; 22(21-22):2392-2408. PubMed ID: 38124367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High
    Lv S; Zhang G; Xie L; Yan Z; Wang Q; Li Y; Zhang L; Han Y; Li H; Du Y; Yang Y; Guo X
    Biomed Res Int; 2020; 2020():2585862. PubMed ID: 32185195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
    Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
    J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.